MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT study

A. Pilotto, F. Schianodicola, E. Premi, R. Grasso, R. Turrone, S. Gipponi, A. Scalvini, E. Cottini, B. Pagherà, V. Garibotto, MC. Rizzetti, L. Bonanni, B. Borroni, S. Morbelli, F. Nobili, UP. Guerra, D. Perani, A. Padovani (Brescia, Italy)

Meeting: 2019 International Congress

Abstract Number: 1951

Keywords: Dementia with Lewy bodies (DLB), Dopamine, Single-photon emission computed tomography(SPECT)

Session Information

Date: Wednesday, September 25, 2019

Session Title: Neuroimaging

Session Time: 1:15pm-2:45pm

Location: Les Muses Terrace, Level 3

Objective: To evaluate the common and divergent dopaminergic and serotonergic impairment in Parkinson’s disease and dementia with Lewy bodies using 123I-FP-CIT imaging.

Background: Striatal dopaminergic pathways are impaired in both PD and DLB. The two conditions might presents with different extrastriatal dopaminergic and serotonergic impairment.  fifty-six PD patients without dementia, 41 DLB patients and 54 controls entered the study. Each patient underwent a standardized neurological examination and 123I-FP-CIT SPECT. For each subject, bindings of nigrostriatal and extrastriatal regions of interest were calculated from spatially normalized images. The occipital-adjusted specific to non-displaceable binding (SBR) in the different regions was compared among PD, DLB and controls adjusting for the effect of age, sex, disease duration and serotonergic/dopaminergic treatment.

Method: Fifty-six PD patients without dementia, 41 DLB patients and 54 controls entered the study. Each patient underwent a standardized neurological examination and 123I-FP-CIT SPECT. For each subject, bindings of nigrostriatal and extrastriatal regions of interest were calculated from spatially normalized images. The occipital-adjusted specific to non-displaceable binding (SBR) in the different regions was compared among PD, DLB and controls adjusting for the effect of age, sex, disease duration and serotonergic/dopaminergic treatment. A covariance analysis provided the correlates of local and long-distance regions with extrastriatal 123I-FP-CIT deficits.

Results: Both PD and DLB patients showed lower 123I-FP-CIT SPECT SBR in several regions beyond the nigrostriatal system, especially the insula, cingulate and thalamus. DLB patients showed significant lower 123I-FP-CIT SBR in thalamus compared to controls and PD patients. Thalamic and cingulate 123I-FP-CIT SBR deficits correlated, respectively, with limbic serotonergic and widespread cortical dopaminergic projections only in DLB patients while exhibited only local correlations in PD patients and controls. P

Conclusion: PD and DLB share insular dopamine deficits, whereas impairment of thalamic serotonergic pathways was specifically associated with DLB. Longitudinal studies will be necessary in order to evaluate the clinical value of extrastriatal 123I-FP-CIT SPECT assessment.

To cite this abstract in AMA style:

A. Pilotto, F. Schianodicola, E. Premi, R. Grasso, R. Turrone, S. Gipponi, A. Scalvini, E. Cottini, B. Pagherà, V. Garibotto, MC. Rizzetti, L. Bonanni, B. Borroni, S. Morbelli, F. Nobili, UP. Guerra, D. Perani, A. Padovani. Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT study [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/extrastriatal-dopaminergic-and-serotonergic-pathways-in-parkinsons-disease-and-in-dementia-with-lewy-bodies-a-123i-fp-cit-study/. Accessed May 21, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/extrastriatal-dopaminergic-and-serotonergic-pathways-in-parkinsons-disease-and-in-dementia-with-lewy-bodies-a-123i-fp-cit-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • The hardest symptoms that bother patients with Parkinson's disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley